Interleukin 2 News and Research

RSS
Phenotypic changes in monocytes from COVID-19 patients

Phenotypic changes in monocytes from COVID-19 patients

5 Apr 2022
Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

5 Apr 2022
Study generates a picture of the myocardial transcriptional landscape of COVID-19

Study generates a picture of the myocardial transcriptional landscape of COVID-19

5 Apr 2022
Higher cereal fiber intake associated with lower inflammation

Higher cereal fiber intake associated with lower inflammation

4 Apr 2022
Animal study provides insights into how COVID-19 can lead to long-term pain

Animal study provides insights into how COVID-19 can lead to long-term pain

4 Apr 2022
Analysis of antioxidants, stress markers in the blood could lead to new diagnostic tool for breast cancer

Analysis of antioxidants, stress markers in the blood could lead to new diagnostic tool for breast cancer

2 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

31 Mar 2022
Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

31 Mar 2022
Study sheds light on biomechanistic reasons why allergic asthma correlates with milder forms of COVID-19

Study sheds light on biomechanistic reasons why allergic asthma correlates with milder forms of COVID-19

31 Mar 2022
Role of SARS-CoV-2 S1 subunit in severe COVID-19

Role of SARS-CoV-2 S1 subunit in severe COVID-19

30 Mar 2022
Researchers discover potential link between inflammation and structure of specific brain regions

Researchers discover potential link between inflammation and structure of specific brain regions

30 Mar 2022
Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

30 Mar 2022
Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

29 Mar 2022
Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

28 Mar 2022
Tuberculosis infection protects mice against COVID-19

Tuberculosis infection protects mice against COVID-19

27 Mar 2022
Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

27 Mar 2022
Study explores macrophage susceptibility to SARS-CoV-2 virions

Study explores macrophage susceptibility to SARS-CoV-2 virions

25 Mar 2022
Researchers investigate Galectin-9 as a new treatment target for COVID-19

Researchers investigate Galectin-9 as a new treatment target for COVID-19

23 Mar 2022
Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

23 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback